NRG ONCOLOGY’s Post

Our abstract titled "A Robust Auto-Segmentation Approach to Accelerate Adaptive MRI-Guided Radiotherapy for Pancreatic Cancer Patients" has been accepted for presentation at the International Conference on the use of Computers in Radiotherapy in Lyon, France, this July. This work showcases a methodology that leverages SynMRI to significantly enhance the performance of auto-segmentation models, ultimately enabling more accurate and efficient adaptive MRI-guided radiotherapy for pancreatic cancer patients. 

Results from a new study support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with advanced non-small cell lung cancer (NSCLC), with fewer side effects and similar survival outcomes. https://lnkd.in/dungZc_Z

Results from a new study support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with advanced non-small cell lung cancer (NSCLC), with fewer side effects and similar survival outcomes. https://lnkd.in/guCRt7gA

Results from a new study support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with advanced non-small cell lung cancer (NSCLC), with fewer side effects and similar survival outcomes. https://lnkd.in/gnP5aT_3

Results from a new study support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with advanced non-small cell lung cancer (NSCLC), with fewer side effects and similar survival outcomes. https://lnkd.in/gHDX9VNP

Results from a new study support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with advanced non-small cell lung cancer (NSCLC), with fewer side effects and similar survival outcomes. https://lnkd.in/eFjY2qzb

Results from a new study support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with advanced non-small cell lung cancer (NSCLC), with fewer side effects and similar survival outcomes. https://lnkd.in/dUij5F8R

Congratulations to Dr Jeremy de Leon, Dr Urszula Jelen, Dr Madeline Carr, David Crawford, Maddison Picton, Charles Tran, Valery Peng, Tania Twentyman, A/Prof Michael Jameson, and Dr Vikneswary Batumalai on the publication of their article, "Apapting outside the box: Simulation-free MR-guided stereotactic ablative radiotherapy for prostate cancer" by the Journal of the European Society for Radiotherapy and Oncology. The publication discusses the successful world-first implementation of a sim-free workflow by the GenesisCare, Darlinghurst team utilising magnetic resonance image guided radiotherapy (MRIgRT) for prostate cancer patients treated with stereotactic ablative radiotherapy (SABR). This approach aims to help reduce the burden on patients by minimising clinic visits and treatment accessibility. Read the article here: https://lnkd.in/gay7Sbre #designingbettercare #cancercare #prostatecancerawarenessmonth #prostatecancer

Results from a new study support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with advanced non-small cell lung cancer (NSCLC), with fewer side effects and similar survival outcomes. https://lnkd.in/e_Au9Ttb

Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial, published in JCO. 👉 Read it before your patients: https://bit.ly/40lrfJF